bmiMD vs Shed: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

48 providers verified independently·Independent research·How we rank →

bmiMD beats Shed overall, scoring 8/10 vs 7.8/10. Shed is more affordable at $199/mo vs $319/mo. Choose bmiMD for budget-first users who want affordable glp-1 access. Choose Shed for users who want fast delivery and a streamlined compounded gl.

A side-by-side comparison of bmiMD and Shed covering pricing, scores, medication types, insurance, and more to help you decide.

Higher Rated

bmiMD

#9 of 48

8/10

Budget-friendly GLP-1 platform offering both medication types at one of the lowest price points in the market.

Visit bmiMD

Shed

#17 of 48

7.8/10

Newer GLP-1 provider focused on speed and simplicity — fast approvals, fast shipping, and a clean user experience at a competitive price point.

Visit Shed

Feature	bmiMD	Shed
Our Score	8/10	7.8/10
Starting Price	$319/mo	$199/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Budget-first users who want affordable GLP-1 access	Users who want fast delivery and a streamlined compounded GLP-1 experience
Ranking	#9	#17

Pros & Cons Compared

bmiMD

Pros

+Same-day physician consults — one of the few platforms offering telehealth appointments the same day you apply
+80,000+ customer base with 4.9-star Trustpilot rating provides strong social proof of reliability
+100% money-back guarantee if your consultation determines you don't qualify for GLP-1 treatment
+HSA/FSA accepted for all programs

Cons

−Starting at $289/mo for semaglutide — significantly more expensive than competitors at $99-199/mo
−$29.99 shipping fee per order — most competitors include free shipping
−$50 non-refundable cancellation fee after intake approval — penalizes patients who change their mind

Shed

Pros

+Industry-leading delivery speed — most patients receive medication within 2-3 days of enrollment
+$149/mo is competitively priced for an all-inclusive compounded program with good support
+Streamlined onboarding with no video call — approved and shipped faster than most competitors
+Clean, modern UX with real-time shipping tracking and easy provider messaging

Cons

−Compounded semaglutide and tirzepatide only — no brand-name options
−Newer company (founded 2024) with limited track record and outcome data
−No insurance billing and no FSA/HSA superbills currently available
−Clinical support is responsive but less proactive than premium platforms

Our Verdict

bmiMD edges out Shed with a score of 8/10 vs 7.8/10. If budget is your priority, Shed starts at $199/mo compared to bmiMD's $319/mo. Choose bmiMD if you want: budget-first users who want affordable glp-1 access. Choose Shed if you want: users who want fast delivery and a streamlined compounded glp-1 experience.

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither bmiMD nor Shed feels like the right fit, our overall #1 pick across all 48 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review